查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621540

转染技术市场：按产品、方法、技术、应用和最终用户划分 - 2025-2030 年全球预测

Transfection Technologies Market by Product (Instrument, Reagent & Kits), Method (Cationic Lipid Transfection, Cotransfection, Electroporation), Technology, Applications, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年转染技术市值为12.2亿美元，预计2024年将达到13.5亿美元，复合年增长率为9.97%，到2030年将达到23.9亿美元。

转染技术包括多种用于将核酸引入真核细胞并促进基因表现、基因静默和基因组编辑的方法。这些技术的需求在于它们在药物发现、基因研究和治疗开发中的关键作用，使其成为分子生物学、遗传学和生物医学研究的宝贵工具。应用范围包括基因表现研究、蛋白质生产和基因疗法开发，最终用途是製药、学术研究机构和生物技术公司。关键的成长要素包括生物分子结构的进步、基因治疗和细胞研究资金筹措的增加以及对合成生物学应用的需求的增加。最近的潜在商机在于CRISPR技术的增强、非病毒转染方法的开发、难以转染的细胞的转染以及公司应透过策略性投资和研究合作来瞄准的新兴机会。然而，诸如高成本、某些试剂的细胞毒性以及原代细胞和体内条件下的递送效率差等挑战对市场成长构成了主要限制。智慧财产权问题和严格的法律规范使市场动态更加复杂。创新应着重于提高转染效率、最大限度地减少细胞毒性、开发新型递送载体以及整合人工智慧来预测和优化转染结果。此外，基于生物分解性聚合物和奈米技术的输送系统的探索代表了潜在的成长途径。儘管市场竞争依然激烈，主导企业已站稳脚跟，但凭藉创新解决方案的新兴企业也有空间在市场上开拓重要的利基市场。总体而言，与技术进步和监管发展保持一致，采用全面的品质保证，并加强对最终用户的教育和支援服务将有助于利用转染技术市场的有希望的成长轨迹。

主要市场统计
基准年[2023] 12.2亿美元
预测年份 [2024] 13.5亿美元
预测年份 [2030] 23.9亿美元
复合年增长率（%） 9.97%

市场动态：揭示快速发展的转染技术市场的关键市场洞察

供需的动态交互作用正在改变转染技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对个人化医疗和生物製药的需求不断增长
    • 开发新型非病毒传递系统并扩大商业性治疗应用的製程规模
    • 增加公共和私人资金用于转染技术的研究和开发
  • 市场限制因素
    • 先进转染技术及相关产品成本相对较高
  • 市场机会
    • 随着mRNA疫苗开发的不断进展，需要一个能够大规模生产的强大转染系统。
    • 为特定细胞类型和应用开发多功能且可客製化的转染试剂和设备
  • 市场挑战
    • 对基因疗法产品和转染技术的严格监管要求

波特五力：驾驭转染技术市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解转染技术市场的外部影响

外部宏观环境因素在塑造转染技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解转染技术市场的竞争格局

转染技术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质转染技术市场供应商绩效评估

FPNV定位矩阵是评估转染技术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定转染技术市场成功之路的策略分析与建议

对于旨在加强其在全球市场的影响力的公司来说，对转染技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化医疗和生物製药的需求不断增长
      • 开发新型非病毒传递系统并扩大商业治疗应用的製程规模
      • 增加公共和私人资金用于转染技术的研究和开发
    • 抑制因素
      • 先进转染技术及相关产品成本相对较高
    • 机会
      • mRNA疫苗的持续开发需要强大的转染系统来满足大规模生产的需求。
      • 为特定细胞类型和应用开发多功能且可客製化的转染试剂和设备
    • 任务
      • 基因治疗产品和转染技术的严格监管要求
  • 市场区隔分析
    • 方法：由于成本效益，基于试剂的方法的重要性日益增加
    • 应用：蛋白质生产在生物製药开发的多种应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章转染技术市场：副产品

  • 装置
  • 试剂和套件

第七章转染技术市场：依方法

  • 阳离子脂质转染
  • 共转染
  • 电穿孔
  • 体内转染
  • 脂转染
  • 核转染

第八章转染技术市场：依技术分类

  • 基于生物化学的转染
  • 物理转染
  • 基于病毒载体的转染

第九章转染技术市场：依应用分类

  • 生物医学研究
  • 基因静默
  • 蛋白质生产
  • 稳定细胞株的产生
  • 干细胞重编程和分化
  • 实施治疗
  • 病毒生产

第10章转染技术市场：依最终用户分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章美洲转染技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太转染技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲转染技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Polyplus 推出 FectoVIR-LV 转染试剂以及新的 DOE 服务选项
    • BioCentriq 和 Kytopen 扩大合作伙伴关係，以加速创新基因编辑技术对细胞治疗製造的影响
    • Avectus 宣布推出 Solpore 平台，用于下一代基因工程细胞疗法的临床製造，具有无与伦比的细胞健康和功能
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Akron Biotech
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Epoch Life Science
  • F. Hoffmann-La Roche AG
  • FUJIFILM Wako Pure Chemical Corporation
  • Geno Technology, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Mirus Bio
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC by Avantor
Product Code: MRR-B16853779807

The Transfection Technologies Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 9.97%, to USD 2.39 billion by 2030.

Transfection technologies encompass a range of methods used to introduce nucleic acids into eukaryotic cells, facilitating gene expression, gene silencing, or genome editing. The necessity of these technologies lies in their critical role in drug discovery, genetic research, and therapeutic development, making them invaluable tools in molecular biology, genetics, and biomedical research. Applications span across gene expression studies, protein production, and development of gene therapies, with significant end-use in pharmaceuticals, academic research institutions, and biotechnology firms. Key growth influences include advancements in biomolecular structures, increased funding in gene therapy and cell-based research, and rising demand for synthetic biology applications. Recent potential opportunities lie in CRISPR technology enhancements, development of non-viral transfection methods, and transfection in difficult-to-transfect cells, representing emerging markets that companies should target through strategic investments and collaborations. However, challenges such as high costs, cytotoxicity of certain reagents, and delivery inefficiency in primary cells or in vivo conditions pose significant limitations to market growth. Intellectual property issues and stringent regulatory frameworks further complicate market dynamics. Innovation should focus on enhancing transfection efficiency, minimizing cytotoxicity, developing novel delivery vectors, and integrating AI to predict and optimize transfection outcomes. Additionally, exploring biodegradable polymers and nanotechnology-based delivery systems presents potential growth avenues. The market nature remains competitive with strong footholds of dominant players yet offers space for novel and emerging companies equipped with innovative solutions to carve out significant market niches. Overall, aligning with technological advancements and regulatory developments, adopting comprehensive quality assurance, and enhancing educational and support services for end users will be crucial in capitalizing on the promising growth trajectory of the transfection technologies market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 2.39 billion
CAGR (%) 9.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transfection Technologies Market

The Transfection Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for personalized medicine and biopharmaceuticals
    • Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
    • Increased public and private funding for research and development in transfection technologies
  • Market Restraints
    • Relatively high cost of advanced transfection technologies and related products
  • Market Opportunities
    • Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
    • Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
  • Market Challenges
    • Stringent regulatory requirements for gene therapy products and transfection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transfection Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transfection Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transfection Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transfection Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transfection Technologies Market

A detailed market share analysis in the Transfection Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transfection Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transfection Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transfection Technologies Market

A strategic analysis of the Transfection Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Akron Biotech, Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Epoch Life Science, F. Hoffmann-La Roche AG, FUJIFILM Wako Pure Chemical Corporation, Geno Technology, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Mirus Bio, OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor.

Market Segmentation & Coverage

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instrument and Reagent & Kits.
  • Based on Method, market is studied across Cationic Lipid Transfection, Cotransfection, Electroporation, In Vivo Transfection, Lipofection, and Nucleofection.
  • Based on Technology, market is studied across Biochemical Based Transfection, Physical Transfection, and Viral-Vector Based Transfection.
  • Based on Applications, market is studied across Bio-Medical Research, Gene Silencing, Protein Production, Stable Cell Line Generation, Stem Cell Reprogramming & Differentiation, Therapeutic Delivery, and Virus Production.
  • Based on End-user, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for personalized medicine and biopharmaceuticals
      • 5.1.1.2. Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
      • 5.1.1.3. Increased public and private funding for research and development in transfection technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of advanced transfection technologies and related products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
      • 5.1.3.2. Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for gene therapy products and transfection technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Method: Rising significance of reagent-based methods due to cost effectiveness
    • 5.2.2. Application: Diverse applications in protein production in biopharmaceutical development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transfection Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Instrument
  • 6.3. Reagent & Kits

7. Transfection Technologies Market, by Method

  • 7.1. Introduction
  • 7.2. Cationic Lipid Transfection
  • 7.3. Cotransfection
  • 7.4. Electroporation
  • 7.5. In Vivo Transfection
  • 7.6. Lipofection
  • 7.7. Nucleofection

8. Transfection Technologies Market, by Technology

  • 8.1. Introduction
  • 8.2. Biochemical Based Transfection
  • 8.3. Physical Transfection
  • 8.4. Viral-Vector Based Transfection

9. Transfection Technologies Market, by Applications

  • 9.1. Introduction
  • 9.2. Bio-Medical Research
  • 9.3. Gene Silencing
  • 9.4. Protein Production
  • 9.5. Stable Cell Line Generation
  • 9.6. Stem Cell Reprogramming & Differentiation
  • 9.7. Therapeutic Delivery
  • 9.8. Virus Production

10. Transfection Technologies Market, by End-user

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Transfection Technologies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transfection Technologies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transfection Technologies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
    • 14.3.2. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
    • 14.3.3. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Akron Biotech
  • 3. Altogen Biosystems
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomol GmbH
  • 6. Epoch Life Science
  • 7. F. Hoffmann-La Roche AG
  • 8. FUJIFILM Wako Pure Chemical Corporation
  • 9. Geno Technology, Inc.
  • 10. Lonza Group
  • 11. Maxcyte Inc.
  • 12. Merck KGaA
  • 13. Mirus Bio
  • 14. OriGene Technologies, Inc.
  • 15. OZ Biosciences SAS
  • 16. Polyplus-transfection SA by Sartorius AG
  • 17. Polysciences, Inc.
  • 18. Promega Corporation
  • 19. Qiagen NV
  • 20. Reprocell Inc.
  • 21. SignaGen Laboratories
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific, Inc.
  • 24. VWR International, LLC by Avantor

LIST OF FIGURES

  • FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENT & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CATIONIC LIPID TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COTRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY IN VIVO TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY NUCLEOFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL-VECTOR BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIO-MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE SILENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STABLE CELL LINE GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STEM CELL REPROGRAMMING & DIFFERENTIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRUS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 243. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023